Chapter
IGF-1 and Aromatase Inhibitors
48:09 - 59:32 (11:22)
The effectiveness of IGF-1 is due to its ability to bind to IGFBP3, which titrates it and delivers it to the tissues. However, some people believe that IGF-1 that does not bind to binding proteins is better, but the opposite is true, as the body breaks it down almost immediately.
Clips
Modified IGF-1 was used in the 90s due to the lack of regular IGF-1 available, but it doesn't bind to IGF-1 binding protein, which is necessary for the body to use it effectively.
48:09 - 51:52 (03:42)
Summary
Modified IGF-1 was used in the 90s due to the lack of regular IGF-1 available, but it doesn't bind to IGF-1 binding protein, which is necessary for the body to use it effectively.
ChapterIGF-1 and Aromatase Inhibitors
Episode#143: The World's Most Famous Performance-Enhancement Chemist
PodcastThe Tim Ferriss Show
Patrick Arnold, the chemist who developed the supplement Six Oxo, explains the process of creating the aromatase inhibitor and the challenges he faced during production.
51:52 - 53:48 (01:56)
Summary
Patrick Arnold, the chemist who developed the supplement Six Oxo, explains the process of creating the aromatase inhibitor and the challenges he faced during production.
ChapterIGF-1 and Aromatase Inhibitors
Episode#143: The World's Most Famous Performance-Enhancement Chemist
PodcastThe Tim Ferriss Show
The speaker recalls going to a show in New Orleans where he was sent the results of a study on Sixoxo and was surprised to see that it worked.
53:49 - 59:32 (05:42)
Summary
The speaker recalls going to a show in New Orleans where he was sent the results of a study on Sixoxo and was surprised to see that it worked. He discusses theories on how it could be used and mentions that his attorneys told him that authorities were taking the substance seriously.